CCN3 (NOV) Is a Negative Regulator of CCN2 (CTGF) and a Novel Endogenous Inhibitor of the Fibrotic Pathway in an in Vitro Model of Renal Disease
Bruce L. Riser(Rosalind Franklin University of Medicine and Science), Sarah C. Riser(Rosalind Franklin University of Medicine and Science)
Cited by 111
Related Papers
CCN3/CCN2 regulation and the fibrosis of diabetic renal disease
|Journal of Cell Communication and Signaling|2010|49